The association between pleural fluid exposure and survival in malignant pleural mesothelioma: a retrospective cohort study in 761 patients

R. Asciak (Oxford, United Kingdom), N. Kanellakis (Oxford, United Kingdom), A. Kidd (Glasgow, United Kingdom), A. Bibby (Bristol, United Kingdom), N. Maskell (Bristol, United Kingdom), K. Blyth (Glasgow, United Kingdom), R. Mercer (Oxford, United Kingdom), P. Fsadni (Msida, Malta), S. Montefort (Msida, Malta), I. Psallidas (Oxford, United Kingdom), N. Rahman (Oxford, United Kingdom)

Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Disease area: Thoracic oncology

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Asciak (Oxford, United Kingdom), N. Kanellakis (Oxford, United Kingdom), A. Kidd (Glasgow, United Kingdom), A. Bibby (Bristol, United Kingdom), N. Maskell (Bristol, United Kingdom), K. Blyth (Glasgow, United Kingdom), R. Mercer (Oxford, United Kingdom), P. Fsadni (Msida, Malta), S. Montefort (Msida, Malta), I. Psallidas (Oxford, United Kingdom), N. Rahman (Oxford, United Kingdom). The association between pleural fluid exposure and survival in malignant pleural mesothelioma: a retrospective cohort study in 761 patients. 4492

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Survival of patients with malignant pleural effusions: a three-year prospective self-experience study
Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma
Year: 2018

Natural course of asymptomatic malignant pleural effusion in non-small-cell lung cancer patients: a multicenter retrospective study
Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology
Year: 2020

Epidemiology, histology and thoracoscopic findings in malignant pleural mesothelioma (MPM) as second tumour in a single-centre cohort
Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions
Year: 2010

Pleurectomy/decortication for malignant pleural mesothelioma: a single-centre experience.
Source: Virtual Congress 2020 – Thoracic surgery: developments in diagnostics and outcomes
Year: 2020


Malignant pleural mesothelioma: clinicopathologic and survival characteristic in a consecutive series of 40 patients
Source: Annual Congress 2009 - Preoperative functional assessment and surgery for malignant diseases
Year: 2009


Correlation between pleural cytology, radiolgy and histology in mesothelioma: a 3 year retrospective study
Source: Annual Congress 2007 - Prognosis and diagnosis of thoracic malignancies
Year: 2007


Survival time in patients with malignant pleural mesothelioma
Source: Annual Congress 2007 - Rare tumours, risk factors and epidemiology in thoracic oncology
Year: 2007


Is there any advantage of chemotherapy on survival of patients with diffuse malignant pleural mesothelioma?
Source: Eur Respir J 2003; 22: Suppl. 45, 29s
Year: 2003

Malignant pleural mesothelioma clinical aspects and survival in 93 cases
Source: Annual Congress 2010 - Current issues in malignant pleural diseases
Year: 2010

Malignant and non-malignant asbestos-related pleural and lung disease: 10-year follow-up study
Source: Eur Respir J 2004; 24: Suppl. 48, 527s
Year: 2004

Retrospective analysis of survival time in malignant pleural effusion requiring IPC insertion
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017

Malignant pleural mesothelioma: CT findings in 49 patients
Source: Eur Respir J 2002; 20: Suppl. 38, 271s
Year: 2002

Prognostic role of inflammatory cells in blood, pleural fluid and tumour samples, in patients with malignant pleural mesothelioma (MPM)
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017


Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients
Source: Eur Respir J 2011; 38: 1425-1430
Year: 2011



A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions
Source: Eur Respir J 2013; 41: 18-24
Year: 2013



LENT Score: predicting the survival of malignant pleural effusion–a prospective study of three years
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019


Malignant pleural mesothelioma (MPM): clinical presentation, complications and survival
Source: Eur Respir J 2002; 20: Suppl. 38, 272s
Year: 2002

Extrapleural pneumonectomy versus pleurectomy/decortication in malignant pleural mesothelioma: an updated meta-analysis of survival endpoints
Source: International Congress 2019 – All aspects of general thoracic surgery
Year: 2019



Pleurodosis through drain for malignant pleural effusion : a case control study
Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction
Year: 2021


Female pleural mesothelioma in a French population-based case-control study
Source: Annual Congress 2009 - Old and new topics in environmental and occupational lung disease
Year: 2009